⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Radioligand Therapy Market to Surge with 13.1% CAGR: Projected Growth from $2.6B in 2025 to $4.8B by 2030 - Novartis' Pluvicto and Lutathera Have Catalyzed Commercial Momentum
globenewswire.com
NVS
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
accessnewswire.com
BDRX
GSK
PFE
NVS
COGT
AAV for the Hereditary Retinal Diseases Competitive Landscape Report 2026: Comprehensive Insights About 75+ Companies and 80+ Drugs
globenewswire.com
NVS
JNJ
FDMT
Monoclonal Antibodies Competitive Landscape Report 2026: Comprehensive Insights About 180+ Companies and 230+ Drugs by Company, Product, Stage of Development, Route of Administration, Molecule Type
globenewswire.com
BMY
GSK
NVS
NVO
Sickle Cell Disease Competitive Landscape Report 2026: Comprehensive Analysis of Over 40 Companies and More Than 50 Drugs
globenewswire.com
NVS
PFE
AGIO
CRSP
TAK
Stem Cell Therapy Market to Reach USD 45.2B by 2036 (8.4% CAGR) | U.S., Germany & Japan Lead Growth | Mesenchymal Stem Cells Hold 45% Share -- Future Market Insights
prnewswire.com
MESO
GERN
BCDA
NVS
BMY
Unnatural Products Announces Licensing Agreement with Novartis to Develop Macrocyclic Peptide Therapeutics
globenewswire.com
UNP
NVS
Novartis remibrutinib first therapy to achieve Phase III primary endpoint in chronic inducible urticaria (CIndU)
globenewswire.com
NVS
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
Conjunctivitis Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research
prnewswire.com
ABBV
JNJ
BHC
NVS